These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


59 related items for PubMed ID: 15357908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
    Ramakrishna L, Anand KK, Mohankumar KM, Ranga U.
    J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of recombinant Modified Vaccinia Ankara Viruses (rMVA) expressing HIV-1 Indian subtype C gag-protease and env-gp120 genes in mice.
    Kumar S, Seth P.
    Viral Immunol; 2004 Sep; 17(4):574-9. PubMed ID: 15671754
    [Abstract] [Full Text] [Related]

  • 7. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
    McGettigan JP, Sarma S, Orenstein JM, Pomerantz RJ, Schnell MJ.
    J Virol; 2001 Sep; 75(18):8724-32. PubMed ID: 11507217
    [Abstract] [Full Text] [Related]

  • 8. Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.
    Wild J, Bojak A, Deml L, Wagner R.
    Vaccine; 2004 Apr 16; 22(13-14):1732-43. PubMed ID: 15068857
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE, Nájera JL, Jiménez V, Bieler K, Wild J, Kostic L, Heidari S, Chen M, Frachette MJ, Pantaleo G, Wolf H, Liljeström P, Wagner R, Esteban M.
    Vaccine; 2007 Mar 01; 25(11):1969-92. PubMed ID: 17224219
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice.
    Da'Dara AA, Lautsch N, Dudek T, Novitsky V, Lee TH, Essex M, Harn DA.
    Vaccine; 2006 Jun 12; 24(24):5211-9. PubMed ID: 16675073
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.
    Deml L, Bojak A, Steck S, Graf M, Wild J, Schirmbeck R, Wolf H, Wagner R.
    J Virol; 2001 Nov 12; 75(22):10991-1001. PubMed ID: 11602739
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.